Prices delayed by 15 minutes
The series is stated in the current share scale after splits; dividends are not included in the price
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| September 16, 2026 | 120.00 | 124.41 | 119.55 | 122.58 | 1m |
| September 15, 2026 | 126.10 | 126.10 | 118.34 | 119.92 | 3m |
| September 14, 2026 | 129.50 | 130.78 | 124.58 | 125.30 | 2m |
| September 11, 2026 | 127.98 | 130.25 |
Based on reports through December 31, 2025
Insmed develops inhaled treatments for the lungs — the drug is delivered straight to the site.
The inhaled route creates a high concentration in the lungs with a modest burden on the body as a whole. The company's first approved drug treats a rare lung infection resistant to ordinary therapy and already brings revenue covering part of development costs.
The main bet is bronchiectasis, a chronic airway condition for which there was essentially no approved treatment. That market is an order of magnitude larger than the current one, and approval changes the company's scale. Such a stock moves on trial data and regulatory decisions rather than on results; development is funded by share issuance and debt. The company pays no dividend.
Address:700 US HIGHWAY 202/206, BRIDGEWATER, NJ, 08807, US
| 1.1bn |
| PFEPfizer, Inc. | 27.64 | +0.66 % | 949m |
| ABTAbbott Laboratories | 102.23 | −0.13 % | 833m |
| VRTXVertex Pharmaceuticals Incorporated | 516.34 | +0.60 % | 553m |
| BMYBristol-Myers Squibb Company | 62.84 | −1.19 % | 539m |
| 126.52 |
| 129.41 |
| 2m |
| September 10, 2026 | 127.22 | 128.85 | 124.29 | 127.28 | 3m |
| September 09, 2026 | 124.00 | 130.83 | 121.04 | 128.80 | 3m |
| September 08, 2026 | 124.78 | 127.42 | 121.38 | 124.89 | 2m |
| September 04, 2026 | 126.00 | 128.24 | 125.62 | 126.29 | 2m |
| September 03, 2026 | 126.70 | 127.09 | 124.05 | 126.68 | 2m |
| September 02, 2026 | 121.11 | 126.79 | 121.11 | 126.63 | 2m |
| September 01, 2026 | 121.95 | 122.19 | 119.52 | 121.51 | 1m |
| August 31, 2026 | 118.68 | 122.71 | 117.51 | 121.82 | 2m |
| August 28, 2026 | 120.11 | 120.66 | 117.15 | 118.54 | 2m |
| August 27, 2026 | 124.67 | 126.10 | 121.21 | 121.39 | 1m |
| August 26, 2026 | 122.89 | 125.59 | 121.64 | 124.39 | 2m |
| August 25, 2026 | 124.65 | 127.18 | 122.87 | 123.89 | 2m |
| August 24, 2026 | 125.03 | 126.11 | 122.83 | 123.98 | 1m |
| August 21, 2026 | 125.22 | 127.20 | 124.82 | 125.77 | 1m |
| August 20, 2026 | 128.36 | 130.27 | 124.60 | 125.08 | 2m |
| August 19, 2026 | 129.85 | 131.10 | 127.42 | 130.66 | 1m |